Global Implantable Cardioverter Defibrillators (ICDs) Market, By Product (Biventricular Implantable Cardioverter Defibrillators, Single Chambered, Dual Chambered), Procedure (Subcutaneous Implantable Cardioverter Defibrillators, Trans-Venous Implantable Cardioverter Defibrillators), Applications (Bradycardia, Tachycardia, Heart Failure, Others), End- User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Implantable Cardioverter Defibrillators (ICDs) Market
The implantable cardioverter defibrillators (ICDs) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 2.9% in the forecast period of 2021 to 2028.
Implantable cardioverter-defibrillator is a small battery-powered machine placed inside the body (chest) and it monitors the heart rhythm and detects the irregular heartbeats. It is capable of cardioversion, defibrillation, and heart rhythm and are generally attached to the heart with the help of the thin wires, which can deliver electric shocks via one or more wires connected to your heart to fix an abnormal heart rhythm. Single chambered, dual chambered, and biventricular implantable cardioverter defibrillators are some of the common product of the ICD.
Factors such as the increasing prevalence of arrhythmia and growing demand for implantable cardioverter defibrillator are further expected to boost the growth of the implantable cardioverter defibrillators (ICDs) market in the forecast period. In addition to this, rising training and awareness programs associated with the ICD further heighten the market's growth. However, the ICD implant can cause infection at the surgical site, which is anticipated to most likely obstruct the growth of the implantable cardioverter defibrillators (ICDs) market in the coming years.
On the other hand, technological advancement and development are to extend further suitable opportunities for the growth of the implantable cardioverter defibrillators (ICDs) market in the near future. ICD can cause many complications such as lead failures, premature battery complications, and others, which are the market's major challenges.
This implantable cardioverter defibrillators (ICDs) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on implantable cardioverter defibrillators (ICDs) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Implantable Cardioverter Defibrillators (ICDs) Market Scope and Market Size
The implantable cardioverter defibrillators (ICDs) market is segmented on the basis of product, procedure, applications and end- user. The growth amongst these segments will help you analyses meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the product, the implantable cardioverter defibrillators (ICDs) market is segmented into biventricular implantable cardioverter defibrillators, single chambered and dual chambered.
- Based on the procedure, the market is segmented into subcutaneous implantable cardioverter defibrillators and trans-venous implantable cardioverter defibrillators. The trans-venous implantable cardioverter defibrillators are sub- segmented into single chamber ICD, dual chamber ICD and CRT-D(cardiac resynchronization therapy- defibrillator).
- On the basis of applications, the market is bifurcated into bradycardia, tachycardia, heart failure and others.
- Based on the end- user, the implantable cardioverter defibrillators (ICDs) market is segmented into hospitals, specialty clinics, ambulatory surgical centers and others.
Implantable Cardioverter Defibrillators (ICDs) Market Country Level Analysis
The implantable cardioverter defibrillators (ICDs) market is segmented on the basis of product, procedure, applications and end- user.
The countries covered in the implantable cardioverter defibrillators (ICDs) market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the implantable cardioverter defibrillators (ICDs) market owing to the surging demand for ICD devices in the region coupled with well-established healthcare infrastructure in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the implantable cardioverter defibrillators (ICDs) market because of the increased incidence of cardiovascular diseases and large geriatric patient population, which is further anticipated to propel the growth of the implantable cardioverter defibrillators (ICDs) market in the region in the coming years.
The country section of the implantable cardioverter defibrillators (ICDs) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The implantable cardioverter defibrillators (ICDs) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for implantable cardioverter defibrillators (ICDs) market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the implantable cardioverter defibrillators (ICDs) market. The data is available for historic period 2010-2019.
Competitive Landscape and Implantable Cardioverter Defibrillators (ICDs) Market Share Analysis
The implantable cardioverter defibrillators (ICDs) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to implantable cardioverter defibrillators (ICDs) market.
The major players covered in the implantable cardioverter defibrillators (ICDs) market report are Boston Scientific Corporation, LivaNova PLC, Medtronic, MicroPort Scientific Corporation, Abbott, BIOTRONIK SE & Co. KG, Physio-Control Inc., Japan Lifeline Co., Ltd, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, FUKUDA DENSHI, Defibtech, LLC, Stryker, Asahi Kasei Corporation, ZOLL Medical Corporation, CU Medical Germany GmbH, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-